小摩增持恒瑞医药387.9413万股 每股作价72.5974港元

Core Viewpoint - JPMorgan has increased its stake in Heng Rui Medicine (600276) to approximately 8.29% by acquiring 3,879,413 shares at a price of HKD 72.5974 per share, totaling around HKD 282 million [1] Group 1 - JPMorgan's latest shareholding in Heng Rui Medicine is approximately 21,413,000 shares [1] - The total amount spent by JPMorgan for the recent acquisition is about HKD 282 million [1] - The increase in shareholding reflects JPMorgan's confidence in Heng Rui Medicine's future prospects [1]